Group cognitive-behavioral therapy with added mobile app and digital monitoring for women with eating disorders and recent suicide risk
Official title: Efficacy of Cognitive-behavioral Therapy (CBT) and Digital Therapy (DT) in the Prevention of Suicide Risk in Patients With Eating Disorders (ED): a Randomized Clinical Trial.
Run by Universitat Autonoma de Barcelona · NCT07417826 · Data updated 2026-11-12
This program will test whether adding a mobile app and digital monitoring to group CBT helps women with eating disorders who recently had suicidal thoughts or attempts.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | Universitat Autonoma de Barcelona Academic / other |
| Locations | 1 site (Sabadell, Barcelona) |
| Status | Recruiting |
| Started | October 22, 2025 |
| Main results expected | October 2028 |
| Study ends | October 2028 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT07417826 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18–65 with a diagnosed eating disorder who have recently experienced suicidal ideation or attempts and are enrolled in the Suicide Risk Code program, are clinically stable, and can give informed consent.
✕Probably not a fit
Patients with bipolar or psychotic disorders, active substance dependence, intellectual disability or cognitive impairment, unstable medical conditions, or those unable to attend the Barcelona site are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women aged 18–65 who are enrolled in the Suicide Risk Code program and have an eating disorder will be assigned to one of two approaches: standard group cognitive-behavioral therapy (CBT) or group CBT plus a mobile application and digital monitoring devices. The digital arm includes a smartphone app and wearable or remote monitoring to track symptoms and safety signals between therapy sessions. Clinical outcomes will focus on suicidal ideation/behaviors and eating-disorder symptoms over the study follow-up period. The trial is conducted at Hospital Universitari Parc Taulí in Sabadell, Barcelona, with participants required to be clinically stable and able to consent.
Why it matters
Potential benefit: If successful, combining digital tools with CBT could reduce suicidal thoughts and improve eating disorder symptoms by enabling ongoing monitoring and more timely support.
How similar studies have gone: Prior research shows CBT and some digital interventions can help eating-disorder symptoms and reduce suicidal ideation in certain groups, but combining group CBT with continuous digital monitoring for suicide risk in this specific population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gender: Female. * Age between 18 and 65 years old. * Clinically stable and able to provide written informed consent. * Subjects included in the "Suicide Risk Code" (Codi Risc Suïcidi - CRS) program due to recent suicidal ideation or suicide attempts. * Patients with a diagnosis of an Eating Disorder (ED). Exclusion Criteria: * Presence of intellectual disability or cognitive impairment that prevents understanding the therapy or the study requirements. * Diagnosis of Bipolar Disorder or any Psychotic Disorder. * Current active substance abuse or dependence. * Any medical condition that, in the investigator's opinion, makes participation unsafe or unfeasible.
Where it's running
-
Hospital Universitari Parc Taulí
Sabadell, Barcelona, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
National Highly Specialized Care for Severe Self-Harm and Eating Disorders in Swedish Youth
This observational study tests how well NHV, a highly specialized care program, works for children and teens with severe self-harm or eating disorders by asking patients and their parents about their experiences and what changes they notice.
-
National Highly Specialized Care for adults with treatment-resistant self-harm and eating disorders (Substudy 1)
This study tests how people with severe, hard-to-turge self-harm or eating disorders in Sweden experience NHV care and whether the treatment helps with symptoms and daily functioning.
-
New Generation Therapies for Suicide: Refining Brief Cognitive Behavioral Therapy
This study tests different sequences and doses of Brief Cognitive Behavioral Therapy to see if it better reduces suicide risk in adults with recent suicidal thoughts or behavior.
-
FlexED: A digital program to help young women see thoughts and feelings about their body in a friendlier way
This trial tests a smartphone-based, gamified ACT-inspired program called FlexED to help young women and girls at risk for eating disorders see how they think and feel about their bodies, and to see if it can be feasibly spread to more people.
-
Impact of GLP-1 Receptor Agonist Therapy vs Structured Lifestyle on Weight and Health
This study tests whether starting a GLP-1 receptor agonist for weight loss works differently from a structured diet-and-exercise program in improving heart and metabolic health for adults with overweight or obesity.
-
FlexED: Full Threshold Body-Image Intervention for Young Women
A mobile, gamified ACT-based program is tested to see if it helps young women with eating disorders feel less distressed about their bodies and reduce symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.